Fimasartan/Amlodipine Combination Phase III

Clinical trial NCT02152306 · COMPLETED

Trial details

NCT number: NCT02152306
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2014-04-01
Primary completion: 2015-03-01
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.